Search Results - "Will, R.K."

A positive rheumatoid factor and X-ray damage predict focal and generalized bone loss in patients with mild rheumatoid arthritis followed over two years by Zhou, Huiqiong, Yao, Ruyu, Wilson, H, Song, S, Breidahl, B, Roff, G, Kent, G.N, Will, R.K

Get full text

A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone by Walsh, J.P, Ward, L.C, Stewart, G.O, Will, R.K, Criddle, R.A, Prince, R.L, Stuckey, B.G.A, Dhaliwal, S.S, Bhagat, C.I, Retallack, R.W, Kent, G.N, Drury, P.J, Vasikaran, S, Gutteridge, D.H

“…Second and third generation bisphosphonates are the treatment of choice for Paget’s disease of bone. These drugs are more effective than calcitonin and…”
Get full text

Arthroscopic evaluation of potential structure-modifying drug in osteoarthritis of the knee: A multicenter, randomized, double-blind comparison of tenidap sodium vs piroxicam by Ayral, X., Mackillop, N., Genant, H.K., Kirkpatrick, J., Beaulieu, A., Pippingskiöld, P., Will, R.K., Alava, S., Dougados, M.

“…Objective: To test the hypothesis that tenidap has a structure-modifying effect in human knee osteoarthritis. Design: Study: multicenter, prospective,…”
Get full text

Arthroscopic evaluation of potential structure-modifying drug in osteoarthritis of the knee by Ayral, X., Mackillop, N., Genant, H.K., Kirkpatrick, J., Beaulieu, A., Pippingskiöld, P., Will, R.K., Alava, S., Dougados, M.

Get full text

Comparison of biochemical markers of bone turnover in paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross‐links by Randall, A.G., Kent, G.N., Garcia‐Webb, P., Bhagat, C.I., Pearce, D.J., Gutteridge, D.H., Prince, R.L., Stewart, G., Stuckey, B., Will, R.K., Retallack, R.W., Price, R.I., Ward, L.

“…We have compared the use of new markers of bone turnover in the assessment and treatment of Paget disease and made observations on the mechanisms of bone…”
Get full text

Paget's disease: Acquired resistance to one aminobisphosphonate with retained response to another by Gutteridge, D.H., Ward, L.C., Stewart, G.O., Retallack, R.W., Will, R.K., Prince, R.L., Criddle, A., Bhagat, C.I., Stuckey, B.G.A., Price, R.I., Kent, G.N., Faulkner, D.L., Geelhoed, E., Gan, S.K., Vasikaran, S.

“…Twenty‐five years after the first paper on etidronate in Paget's disease, there are few published papers that address bisphosphonate resistance as a specific…”
Get full text

A randomized treatment trial of intravenous pamidronate and oral alendronate in Paget’s disease: early results by Gutteridge, D.H, Ward, L.C, Stewart, G.O, Retallack, R.W, Prince, R.L, Bhagat, C.I, Stuckey, B.G.A, Will, R.K, Kent, G.N, Price, R.I, Gan, S.K

Get full text